Calif. molecular Dx firm could bring in $1.9M from stock sale

09/23/2013 | GenomeWeb Daily News (free registration)

Response Genetics hopes to secure $1.9 million in a direct offering of shares. The Los Angeles molecular diagnostics company will use the money to expedite integration of the Tissue of Origin assay it acquired from Pathwork Diagnostics. The test has FDA clearance for identifying undifferentiated, poorly differentiated and metastatic cancers.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA